Breaking

Archive

Dec 2 results
19:05
19:05

Researchers Studying New PrEP Drug in HIV Vaccine Trial HIV vaccine trials 4

Dr Eugene Ruzagira, a member of the team of researchers told a news conference organized by the Health Journalists Network that they are giving all the participants in their PrEPVACC trial a daily Descovy tablet to assess whether it’s effective in preventing participants from getting infected.
16:44
16:44

157 Ugandans Enrolled in Largest HIV Vaccine Trial in Africa HIV vaccine trials 3 1

The study dubbed PrEPVACC is also happening in Mbeya and Dar-es-Salaam in Tanzania, Maputo in Mozambique and in Durban South Africa, but Uganda has so far registered the biggest number of the 1700 total participants they are seeking.
Dec 2 results